Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2936-2026Class II

BIOFIRE Respiratory Panel 2.1 (RP2.1) REF 423742 UDI code: 00815381020529 PCR-based multiplexed nucleic acid...

BioFire Diagnostics, LLC / initiated 2026-06-24 / Open, Classified

BioFire Diagnostics, LLC began a recall of BIOFIRE Respiratory Panel 2.1 (RP2.1) REF 423742 UDI code: 00815381020529 PCR-based multiplexed nucleic acid test, in vitro diagnostic on . FDA classified it as Class II and gives the reason as "Due to increase in false negative results". As of , the recall status on record is Open, Classified.

Recall record

Recall number
Z-2936-2026
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
BioFire Diagnostics, LLC
Product
BIOFIRE Respiratory Panel 2.1 (RP2.1) REF 423742 UDI code: 00815381020529 PCR-based multiplexed nucleic acid test, in vitro diagnostic
Product code
QOF Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents
Reason for recall
Due to increase in false negative results
FDA root cause
Under Investigation by firm
Action
On 06/24/2026, an "URGENT MEDICAL DEVICE CORRECTION" Letter was emailed to customers informing them that bioMrieux received complaints of false-negative results associated with BIOFIRE RP2.1 kit lot 1872125 / pouch lot 3VLB25. An internal investigation confirmed the presence of incorrect PCR1 primers in a subset of pouches within BIOFIRE RP2.1 kit lot 1872125 introduced during reagent manufacturing. This field safety notice was issued because the incorrect PCR1 primers will lead to pouch pathogen assay negative results with passing control assays. Customers are instructed to: "Examine your inventory for the lot identified in this field safety notice. "Cease use and discard any remaining product from this lot in your possession. "Confirm the quantity of kits that have been destroyed, previously used, or returned on the attached Acknowledgement of Receipt Form. "If you have further distributed this product, please identify any recipients and notify them at once. "Complete the accompanying Acknowledgement of Receipt Form and return to bioMrieux so that bioMrieux may acknowledge your receipt of this notification. "bioMerieux will be providing pouch credit for affected products. For Questions - contact local Customer Service Representative at (800) 682-2666. For non-urgent inquiries, contact the Technical Support Center by email at [email protected].
Quantity in commerce
2,370 pouches (79 kits)
Distribution
U.S. Nationwide distribution in the states of AL, AR, IA, IL, KS, LA, MN, MO, TX, and WI.
Product codes and lots
Part Number: 423742 UDI-DI code: 00815381020529 Pouch Lot: 3VLB25 Kit Lot: 1872125

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2936-2026
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2936-2026Class IIOngoingVoluntary: Firm initiated